Evidence map›Paper›PMID 40636872›Full record

ArticleFrontiers in public health2025

The disease burden of pneumoconiosis in China from 1990 to 2021 and projection to 2050 based on GBD 2021: a cross-sectional study.

Xiangwen Gong, Kaiwang Cui, Zhi Liu, Yongtong Tang, Jingbo Li, Youmei Chen, Zhangshun Tu, Miaomiao Yuan, Jianping Liu, Haiwu Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiangwen Gong *Department of Respiratory and Critical Care Medicine, Ganzhou Key Laboratory of Respiratory Diseases, Ganzhou Institute of Respiratory Diseases, The Fifth People's Hospital of Ganzhou, Ganzhou, China.
Kaiwang Cui *Department of Respiratory and Critical Care Medicine, Ganzhou Key Laboratory of Respiratory Diseases, Ganzhou Institute of Respiratory Diseases, The Fifth People's Hospital of Ganzhou, Ganzhou, China.
Zhi Liu *Department of Respiratory and Critical Care Medicine, Xingguo County Pulmonary Hospital, Ganzhou, China.
Yongtong TangDepartment of Respiratory and Critical Care Medicine, The People's Hospital of Shangyou, Ganzhou, China.
Jingbo LiDepartment of Respiratory and Critical Care Medicine, Ganzhou Key Laboratory of Respiratory Diseases, Ganzhou Institute of Respiratory Diseases, The Fifth People's Hospital of Ganzhou, Ganzhou, China.
Youmei ChenDepartment of Respiratory and Critical Care Medicine, Ganzhou Key Laboratory of Respiratory Diseases, Ganzhou Institute of Respiratory Diseases, The Fifth People's Hospital of Ganzhou, Ganzhou, China.
Zhangshun TuSchool of Rehabilitation Medicine, Gannan Medical University, Ganzhou, China.
Miaomiao YuanSchool of Rehabilitation Medicine, Gannan Medical University, Ganzhou, China.
Jianping LiuDepartment of Respiratory and Critical Care Medicine, Ganzhou Key Laboratory of Respiratory Diseases, Ganzhou Institute of Respiratory Diseases, The Fifth People's Hospital of Ganzhou, Ganzhou, China.
Haiwu WuDepartment of Respiratory and Critical Care Medicine, Ganzhou Key Laboratory of Respiratory Diseases, Ganzhou Institute of Respiratory Diseases, The Fifth People's Hospital of Ganzhou, Ganzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pneumoconiosis is a serious occupational disease with high incidence and prevalence in China. This study aimed to describe the long-term trends in the burden of pneumoconiosis and its epidemiological characteristics in China over the past 30 years. Methods: Data from this cross-sectional study were obtained from the Global Burden of Disease (GBD) 2021 study. Joinpoint was used to calculate the annual average percentage change (AAPC), and age-period-cohort (APC) analyses were used to assess trends in the burden of pneumoconiosis. The Bayesian age-period-cohort (BAPC) model was used to forecast pneumoconiosis burden from 2022 to 2050. Results: From 1990--2021, the age-standardized incidence rate (ASIR) and mortality rate (ASMR) of pneumoconiosis in China declined from 2.2 (1.83, 2.59) to 1.42 (1.21, 1.63) and from 0.9 (0.73, 1.09) to 0.41 (0.32, 0.53) cases per 100,000 people. The AAPCs of the ASIR and ASMR were -1.42% and -2.15%, respectively. The age-standardized disability-adjusted life years (DALY) and years of life lost (YLL) also decline from 24.32 (20.05, 29.47) to 10.86 (8.49, 13.87) and from 22.39 (18.13, 27.51) to 9.38 (7.1, 12.32) years per 100,000 persons. APC analyses revealed that the incidence and mortality risk of pneumoconiosis increased with age, decreased with period, and were greater in the early birth cohort. From 2022 to 2025, the ASIR and ASPR are expected to remain relatively stable, while the ASMR is projected to decline significantly to 0.267/100,000 in 2050. Conclusion: Despite the downward trend in age-standardized disease burden indicators of pneumoconiosis, the burden of pneumoconiosis remains heavy due to the large occupational population in China.

Indexed as

Cost of IllnessPneumoconiosisAdultAgedChinaCross-Sectional StudiesFemaleForecastingGlobal Burden of DiseaseHumansIncidenceMaleMiddle AgedPrevalenceChinacross-sectional studyepidemiologic studiesglobal burden of diseasepneumoconiosis

Identifiers

PMID40636872
PMCPMC12238073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.